Harvard Bioscience to Buy Back $10M in Stock

Xconomy Boston — 

Harvard Bioscience (NASDAQ: HBIO), a Holliston, MA-based maker of instrumentation for life sciences industries, plans to buy back some $10 million of its common stock over the next two years, the company announced yesterday. The stock is up some 6 percent this afternoon, at $4.24.